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1. Introduction 
Cholera toxin consists of two subunits, A and B, in 
a molar ratio of 1 A to 5 B [ 1,2] . Subunit A is respon- 
sible for the action of cholera toxin in stimulating the 
production of CAMP in the cell, and subunit B, for 
the binding of the toxin to the cell surfaces (reviewed 
[3] ). The A subunit is composed of two polypeptides, 
A, (M, 22 000) and A2 (M, 7500), linked to each 
other by a single disulfide bond [l] . It has been shown 
that polypeptide Al, separated from AZ, is the only 
component of cholera toxin capable of activating the 
adenylate cyclase activity in a membrane preparation 
of pigeon erythrocytes [4]. 
We report here the isolation of four peptides 
resulting from BrCN cleavage of the A, subunit and 
the elucidation of their linear alignments. This work 
has provided not only the necessary information for 
determination of the complete sequence but also 
insight into the molecular make-up of subunit Al. 
2. Materials and methods 
Cholera toxin was purified from the culture filtrate 
of V. cholerae, strain 569 B, with the modified proce- 
dure [.5] .
Subunits were separated by gel filtration on 
Sephadex G-75 in 5% HCOOH as in [l] . For the 
isolation of polypeptide Al, subunit A was dissolved 
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in 0.4 M Tris-Cl buffer (PH 8.5), containing 0.01 M 
dithiothreitol (DTT), 0.02 M EDTA and 8 M urea for 
2 h and gel filtered on Sephadex G-75 in 5% HCOOH 
containing 1 mM DTT. S-carboxymethyl (CM) A1 
peptide was prepared similarly after reduction and 
S-carboxymethylation of subunit A in 8 M urea [6] . 
Purity of these preparations was ascertained by acryl- 
amide-gel electrophoresis in 0.1% SDS and 8 M urea, 
as well as by amino acid analysis [l] . 
Sequential degradations of peptides were performed 
according to Edman’s procedure [7], manually as in 
[8], or automatically in a Beckman Model 890C 
sequencer (Beckman Instrument Co., Palo Alto, CA). 
The amino acid degraded at each step was identified 
by amino acid analysis after regeneration in 5.7 N HCl 
containing SnClz [9]. 
Amino acid analyses were performed with a Joel 
Model 5AH automatic analyzer (JEOL, USA Inc., 
Medford, NJ) or with a microcolumn analyzer equip- 
ped with the fluorescamine detector system [lo] con- 
structed in this laboratory. For the analyses of homo- 
serine, asparagine and glutamine, the column was 
operated at 32°C. 
3. Results 
3.1. Separation and characterization of the BrCN 
fragments of polypep tide A 1 
Polypeptide A1 had been found to contain 3 
methionine residues/mol. When the BrCN cleavage 
product [ 1 l] of the S-carboxymethylated peptide A, 
was chromatographed on Sephadex G-50 in 5% 
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Fig.1. Sephadex G-50F chromatography of BrCN peptides 
from cholera toxin subunit A, : S-[‘4C]carboxymethyl poly- 
peptide A, (5 mg in 0.5 ml 70% HCOOH) was treated with 
2.1 mg BrCN in 50 ~170% HCOOH for 22 h at room temper- 
ature. After dilution with water and lyophihzation, the cleav- 
age product was gel filtered on a column (1.5 X 180 cm) of 
Sephadex G-50F in 5% HCOOH at room temperature. The 
flow rate was 12 ml/h and fractions (1 ml) were collected. 
Aliquots (0.1 ml) were analyzed for peptides with fluoresc- 
amine after hydrolysis (-) and for radioactivity (30 ~1) 
(- - -). 
HCOOH, 4 peptides were separated in excellent yields 
(fig.1). The small peak appearing before the first major 
peak was obtained in varying yields from experiment 
to experiment (O-IS% of the total peak area) and 
was considered an artifact of the BrCN reaction. The 
four major peaks were designated Cn I, Cn II, Cn III 
and Cn IV, in the order of their elution from the 
column (fig.1). 
The purity of BrCN peptides Cn I-Cn IV was 
established by amino acid analyses and the end group 
analyses; Cn I contained the only CM-cysteine residue 
in polypeptide A1 [ 1,131 . Peptides Cn I and Cn II 
were devoid of Lys; Cn III of His, Thr and Val; and 
Cn IV of Lys, His, Ala, Ile and Leu. All but Cn I con- 
tained homoserine residue. One-step Edman degrada- 
tion on each peptide showed a single NH*-terminal 
residue for each;Phe for Cn I, Asx for Cn II and Cn III, 
and Pro for Cn IV. Since the NH*-terminus of the 
parent peptide Ai has been determined as asparagine 
[ 14,151 , either Cn II or Cn III is indicated as derived 
from the NH,-terminus of Ai. 
3.2. Sequence analyses of pep tides A ,, Cn I, Cn II, 
Cn III and Cn IV 
Edman degradation was carried out manually [8] 
or with an automatic sequencer on about 5 nmol or 
100 nmol of the samples, respectively (table 1). The 
results provided further evidence for chemical purity 
of these peptides. The NH*-terminal BrCN peptide 
has been identified as Cn III. 
Peptide Cn I was the only peptide which did not 
yield homoserine on acid hydrolysis. Digestions of 
the BrCN peptides with carboxypeptidase A (10 pg 
for 5-6 nmol peptides in 0.1 ml 0.2 MN-ethyl- 
morpholine acetate buffer (pH 8.5) at 37°C) released 
the following amino acids (expressed in mol fractions) 
at the specified time intervals: 
Polypeptide Al: 1 h - Ser (0.14), Gly (0.12); 5 h - 
Ser (0.20), Gly (0.18), Asn (0.1) 
Cn I: 1 h - Ser (0.14), Gly (0.12); 5 h - Ser (0.20), 
Gly (0.18), Ala, Leu (0.13), Asn (0.1) 
Cn II: 1 h - Hse (0.133); 7 h - Hse (0.17), Leu 
(0.077) 
Cn III: 10 min - Hse (0.49), Leu (0.51) Gly (0.06), 
Ser (0.04); 1 h - Hse (0.81), Leu (1.49), Gly 
(0.09) Ser (0.05) 
Cn IV: 30 min - Hse (0.37), Gln (0.30), Thr (0.09), 
Gly (0.06); 1 h - Hse (0.59), Gln (0.43) Thr 
(0.14) Gly (0.1). 
The results summarized in table 1, confirmed that 
Cn I was from the COOH-terminus of polypeptide A1 . 
The arrangement of BrCN peptides is indicated to be 
(NH,)Cn III-(Cn II, Cn IV)-Cn I (COOH). 
3.3. Isolation of the peptides containing overlaps for 
BrCN fragments from the tryptic digest of 
CM-pep tide A 1 
In order to obtain information on the linkage 
between BrCN peptides, CM-peptide A1 was digested 
with trypsin, and the peptides containing methionine 
were separated (fig.2). These peptides would contain 
overlaps between the BrCN peptides. Three such pep- 
tides, Tl from initial separation on Sephadex G-25 
(fig.2A), T3b from DEAE-cellulose chromatography 
of T3 fraction (fig.2B), and T4h from Dowex 50 
chromatography of T4 fraction (tig.2C) were obtained 
in 82%, 69% and 75% yields, respectively. 
3.4. Alignment of the BrCNpeptides 
The methionine-containing peptides (overlap) had 
the following compositions: 
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Tl - Asp,Thr4Ser5Glu6ProsGly,Ala,Val,Met111es 
Leu6Tyr,Phe2HisaArg1 
T3b - Asp,ThrlGlu,GlylAlarMetlIlelLeulTyrlHisl 
Arg, (13 residues) 
T4h - Asp1Ser1Glu1Pro1Gly2Met1LeurArg, (9 resi- 
dues) 
Fig.2. Separation of tryptic peptides containing methionine 
residues: S-[“‘CJcarboxymethyl A, (6 mg) was digested with 
50 clg TPCK-trypsin in 1 ml 0.05 M Tris-HCl buffer (pH 8.7) 
for 6 h at 37°C. (A) The digest was gel filtered on a Sephadex 
G-25F column (1.5 X 180 cm) in 0.1 M NH,HCO, at 
14 ml/h. Fractions (2 ml) were collected. For the fluorimetry 
of peptides (-), 0.1 ml aliquots were used, and for radio- 
activity (- - -) 20 ~1. Amino acid analyses on combined frac- 
tions showed that all methionine residues were recovered in 
fractions Tl, T2 and T3. (B) Fraction T3 above was chro- 
matographed on a DEAE-cellulose column (DE-52, 
1 x 30 cm) in 0.05 M NH,HCO, (pH 8.5). Elution was 
carried out with a concentration gradient of the buffer as 
shown (- - -). The flow rate was 12 ml/h and 1.5 ml fractions 
were collected. Aliquots (0.1 ml) were used for the fluoresc- 
amine analysis (-). (C) The Sephadex G-25 fraction T4 
(fig.2A) was chromatographed on a column (0.9 X 27 cm) 
of Aminex AGSOW x 4, with a pyridine-acetate buffer 
gradient as indicated (- - -). The flow rate was 12 ml/h and 
fractions (1.6 ml) were collected. Aliquots (0.21 ml) were 
used for the fluorescamine assay (-_). 
In Cn I, no Lys or Arg was found in the NH,-terminal 
segment of at least 15 residues (table 1). Only Tl 
(73 residues) could contain overlap for Cn I. 
The sequence of T3b was found to be: 
Gly-Thr-Glu-Met-Asx(Asx2AlalLeu1TyrlHis,)- 
Arg 
by Edman degradation. On BrCN cleavage, this peptide 
yielded a peptide, ThriGlyrGluiHsei. The results 
indicated that T3b overlapped Cn IV and Cn II 
(table 1). 
The above argument indicated that T4h overlapped 
Cn III and Cn IV. This was confirmed by isolation 
and analyses of peptide Pro-Arg (NH2-terminus of 
Cn IV) on BrCN treatment of T4h and paper electro- 
phoresis. The arrangement of BrCN peptides is there- 
fore : 
CnIII- -CnIV- -CnII- -CnI (fig.3). 
Fig.3. Schematic sketch of the primary structure of cholera toxin subunit A,. The numbers from the NH,-terminus are indicated. 
The lower bars indicate the tryptic peptides containing overlaps between BrCN fragments. The figures in parentheses denote the 
number of residues in the peptides. The dotted lines indicate the area where the sequences are known. 
88 
Volume 100, number I FEBS LETTERS April 1979 
4. Discussion Acknowledgements 
Although peptides Cn I and Cn II are still large in 
size (92 and 60 residues, respectively), the task of 
sequence analyses on these peptides is considerably 
reduced from that on the entire polypeptide A,. 
Tentative sequence of altogether 68 residues have 
been determined (table 1) and shall be of value in the 
elucidation of the complete primary structure. 
Knowledge on the alignment of BrCN fragments and 
their amino acid composition shall also be useful for 
mapping specific sidechain functions or sites involved 
in a variety of reactions on polypeptide A1 . 
The sum of amino acid residues in the four BrCN 
peptides is in good agreement with the amino acid 
composition of polypeptide AI [l] . A schematic 
diagram of the subunit Ar (fig.3) has revealed interest- 
ing features of this molecule. The only two lysine 
residues are found within a 1 /lOth segment of the 
polypeptide chain at the NH,-terminus. Arginine resi- 
dues, as much as 141mo1, are distributed among 50% 
of the chain, which excludes the 73-residue stretch 
(37% of the chain length) corresponding to peptide 
Tl situated near the center of the molecule (flg.3). 
Tryptophan was detected in peptides Cn I and Cn II 
by spot-test on paper [ 151 . The single cysteine resi- 
due of subunit Ai is located in the COOH-terminal 
quarter of the peptide chain, for it is found in peptide 
Cn I but not in Tl (fig.l,2). This area must contain 
the active site responsible for the stimulation of 
adenylate cyclase since the activity of subunit A 
greatly increases on cleavage of the disulfide bond 
f41. 
Polypeptides Ai and AZ have been su~ested to 
derive from a single precursor peptide [ 161. In view 
of the present finding, the precursor peptide would 
probably be synthesized from the NH,-terminus of 
AZ, ending in the COOH-terminus of Ar . Disulfide 
formation between cysteine residues near both ends 
woutd then occur, followed by the proteolysis at the 
other side of the loop. 
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